Showing results (241-250 of 281) with videos related to
Sort By:
Pageof 29
The Journal of Clinical Investigation|October 12, 2018
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic targetJun Wei, Anantha Marisetty, Brett Schrand, et al.Genes & Development|March 15, 2017
Oncogenic Kras drives invasion and maintains metastases in colorectal cancerAdam T Boutin, Wen-Ting Liao, Melody Wang, et al.BJU International|August 17, 2023
Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified studyKyle A Blum, Andrew W Silagy, Andrea Knezevic, et al.Genes & Development|April 18, 2012
Emerging insights into the molecular and cellular basis of glioblastomaGavin P Dunn, Mikael L Rinne, Jill Wykosky, et al.Nature Communications|May 3, 2020
Effective combinatorial immunotherapy for penile squamous cell carcinomaTianhe Huang, Xi Cheng, Jad Chahoud, et al.Nature|February 7, 2017
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancerDi Zhao, Xin Lu, Guocan Wang, et al.Nature Genetics|September 18, 2024
Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneityAteeq M Khaliq, Meenakshi Rajamohan, Omer Saeed, et al.Cancer Cell|May 19, 2010
PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomasHongwu Zheng, Haoqiang Ying, Ruprecht Wiedemeyer, et al.Bioorganic & Medicinal Chemistry Letters|July 15, 2009
Respiratory syncytial virus fusion inhibitors. Part 7: structure-activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivoNy Sin, Brian L Venables, Keith D Combrink, et al.Bioorganic & Medicinal Chemistry Letters|December 22, 2005
Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivoKuo-Long Yu, Xiangdong Alan Wang, Rita L Civiello, et al.Pageof 29